Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2010

Open Access 01-12-2010 | Review

Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism

Authors: Laurence Amar, Pierre-François Plouin, Olivier Steichen

Published in: Orphanet Journal of Rare Diseases | Issue 1/2010

Login to get access

Abstract

Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia. Unilateral aldosterone hypersecretion is caused by an aldosterone-producing adenoma (also known as Conn's adenoma and aldosteronoma), primary unilateral adrenal hyperplasia and rare cases of aldosterone-producing adrenocortical carcinoma. In these forms, unilateral adrenalectomy can cure aldosterone excess and hypokalemia, but not necessarily hypertension. The prevalence of primary aldosteronism in the general population is not known. Its prevalence in referred hypertensive populations is estimated to be between 6 and 13%, of which 1.5 to 5% have an aldosterone-producing adenoma or primary unilateral adrenal hyperplasia. Taking into account referral biases, the prevalence of surgically correctable primary aldosteronism is probably less than 1.5% in the hypertensive population and less than 0.3% in the general adult population. Surgically correctable primary aldosteronism is sought in patients with hypokalemic, severe or resistant forms of hypertension. Recent recommendations suggest screening for primary aldosteronism using the aldosterone to renin ratio. Patients with a raised ratio then undergo confirmatory suppression tests. The differential diagnosis of hypokalemic hypertension with low renin includes mineralocorticoid excess, with the mineralocorticoid being cortisol or 11-deoxycorticosterone, apparent mineralocorticoid excess, pseudo-hypermineralocorticoidism in Liddle syndrome or exposure to glycyrrhizic acid. Once the diagnosis is confirmed, adrenal computed tomography is performed for all patients. If surgery is considered, taking into consideration the clinical context and the desire of the patient, adrenal vein sampling is performed to detect whether or not aldosterone hypersecretion is unilateral. Laparoscopic surgery for unilateral aldosterone hypersecretion is associated with a morbidity of about 8%, with most complications being minor. It generally results in the normalization of aldosterone secretion and kalemia, and in a large decrease in blood pressure, but normotension without treatment is only achieved in half of all cases. Normotension following adrenalectomy is more frequent in young patients with recent hypertension than in patients with long-standing hypertension or a family history of hypertension.
Appendix
Available only for authorised users
Literature
1.
go back to reference Conn JW: Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955, 45: 3-17.PubMed Conn JW: Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955, 45: 3-17.PubMed
2.
go back to reference Conn JW, Cohen EL, Rovner DR: Suppression of Plasma Renin Activity in Primary Aldosteronism. Jama. 1964, 190: 213-21.PubMed Conn JW, Cohen EL, Rovner DR: Suppression of Plasma Renin Activity in Primary Aldosteronism. Jama. 1964, 190: 213-21.PubMed
3.
go back to reference Funder JW, Carey RM, Fardella C, et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008, 93: 3266-81. 10.1210/jc.2008-0104.CrossRefPubMed Funder JW, Carey RM, Fardella C, et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008, 93: 3266-81. 10.1210/jc.2008-0104.CrossRefPubMed
4.
go back to reference Newton-Cheh C, Guo CY, Gona P, et al: Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007, 49: 846-56. 10.1161/01.HYP.0000258554.87444.91.CrossRefPubMed Newton-Cheh C, Guo CY, Gona P, et al: Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007, 49: 846-56. 10.1161/01.HYP.0000258554.87444.91.CrossRefPubMed
5.
go back to reference Nishikawa T, Omura M: Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother. 2000, 54 (Suppl 1): 83s-5s. 10.1016/S0753-3322(00)80019-0.CrossRefPubMed Nishikawa T, Omura M: Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother. 2000, 54 (Suppl 1): 83s-5s. 10.1016/S0753-3322(00)80019-0.CrossRefPubMed
6.
go back to reference Mulatero P, Stowasser M, Loh KC, et al: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004, 89: 1045-50. 10.1210/jc.2003-031337.CrossRefPubMed Mulatero P, Stowasser M, Loh KC, et al: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004, 89: 1045-50. 10.1210/jc.2003-031337.CrossRefPubMed
7.
go back to reference Rossi GP, Bernini G, Caliumi C, et al: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006, 48: 2293-300. 10.1016/j.jacc.2006.07.059.CrossRefPubMed Rossi GP, Bernini G, Caliumi C, et al: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006, 48: 2293-300. 10.1016/j.jacc.2006.07.059.CrossRefPubMed
8.
go back to reference Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A: Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res. 2007, 30: 111-7. 10.1291/hypres.30.111.CrossRefPubMed Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A: Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res. 2007, 30: 111-7. 10.1291/hypres.30.111.CrossRefPubMed
9.
go back to reference Douma S, Petidis K, Doumas M, et al: Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008, 371: 1921-6. 10.1016/S0140-6736(08)60834-X.CrossRefPubMed Douma S, Petidis K, Doumas M, et al: Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008, 371: 1921-6. 10.1016/S0140-6736(08)60834-X.CrossRefPubMed
10.
go back to reference Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F: High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens. 2002, 15: 896-902. 10.1016/S0895-7061(02)02969-2.CrossRefPubMed Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F: High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens. 2002, 15: 896-902. 10.1016/S0895-7061(02)02969-2.CrossRefPubMed
11.
go back to reference Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365: 217-23.CrossRefPubMed Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365: 217-23.CrossRefPubMed
12.
go back to reference Abasiyanik A, Oran B, Kaymakci A, Yasar C, Caliskan U, Erkul I: Conn syndrome in a child, caused by adrenal adenoma. J Pediatr Surg. 1996, 31: 430-2. 10.1016/S0022-3468(96)90753-8.CrossRefPubMed Abasiyanik A, Oran B, Kaymakci A, Yasar C, Caliskan U, Erkul I: Conn syndrome in a child, caused by adrenal adenoma. J Pediatr Surg. 1996, 31: 430-2. 10.1016/S0022-3468(96)90753-8.CrossRefPubMed
13.
go back to reference Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE: The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum Hypertens. 1988, 2: 187-9.PubMed Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE: The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum Hypertens. 1988, 2: 187-9.PubMed
14.
go back to reference Takayanagi R, Miura K, Nakagawa H, Nawata H: Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother. 2000, 54 (Suppl 1): 164s-8s. 10.1016/S0753-3322(00)80036-0.CrossRefPubMed Takayanagi R, Miura K, Nakagawa H, Nawata H: Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother. 2000, 54 (Suppl 1): 164s-8s. 10.1016/S0753-3322(00)80036-0.CrossRefPubMed
15.
go back to reference Obara T, Ito Y, Okamoto T, et al: Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery. 1992, 112: 987-93.PubMed Obara T, Ito Y, Okamoto T, et al: Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery. 1992, 112: 987-93.PubMed
16.
go back to reference Gleason PE, Weinberger MH, Pratt JH, et al: Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. J Urol. 1993, 150: 1365-8.PubMed Gleason PE, Weinberger MH, Pratt JH, et al: Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. J Urol. 1993, 150: 1365-8.PubMed
17.
go back to reference Proye CA, Mulliez EA, Carnaille BM, et al: Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?. Surgery. 1998, 124: 1128-33. 10.1067/msy.1998.93108.CrossRefPubMed Proye CA, Mulliez EA, Carnaille BM, et al: Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?. Surgery. 1998, 124: 1128-33. 10.1067/msy.1998.93108.CrossRefPubMed
18.
go back to reference Sawka AM, Young WF, Thompson GB, et al: Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001, 135: 258-61.CrossRefPubMed Sawka AM, Young WF, Thompson GB, et al: Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001, 135: 258-61.CrossRefPubMed
19.
go back to reference Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G: Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg. 2005, 71: 864-9.PubMed Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G: Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg. 2005, 71: 864-9.PubMed
20.
go back to reference Pang TC, Bambach C, Monaghan JC, et al: Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg. 2007, 77: 768-73. 10.1111/j.1445-2197.2007.04225.x.CrossRefPubMed Pang TC, Bambach C, Monaghan JC, et al: Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg. 2007, 77: 768-73. 10.1111/j.1445-2197.2007.04225.x.CrossRefPubMed
21.
go back to reference Rossi GP, Bolognesi M, Rizzoni D, et al: Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008, 51: 1366-71. 10.1161/HYPERTENSIONAHA.108.111369.CrossRefPubMed Rossi GP, Bolognesi M, Rizzoni D, et al: Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008, 51: 1366-71. 10.1161/HYPERTENSIONAHA.108.111369.CrossRefPubMed
22.
go back to reference Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008, 26: 1816-23. 10.1097/HJH.0b013e3283060f0c.CrossRefPubMed Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008, 26: 1816-23. 10.1097/HJH.0b013e3283060f0c.CrossRefPubMed
23.
go back to reference Zarnegar R, Bloom AI, Lee J, et al: Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?. J Vasc Interv Radiol. 2008, 19: 66-71. 10.1016/j.jvir.2007.08.022.CrossRefPubMed Zarnegar R, Bloom AI, Lee J, et al: Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?. J Vasc Interv Radiol. 2008, 19: 66-71. 10.1016/j.jvir.2007.08.022.CrossRefPubMed
24.
go back to reference Zarnegar R, Young WF, Lee J, et al: The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008, 247: 511-8. 10.1097/SLA.0b013e318165c075.CrossRefPubMed Zarnegar R, Young WF, Lee J, et al: The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008, 247: 511-8. 10.1097/SLA.0b013e318165c075.CrossRefPubMed
25.
go back to reference Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002, 40: 892-6. 10.1161/01.HYP.0000040261.30455.B6.CrossRefPubMed Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002, 40: 892-6. 10.1161/01.HYP.0000040261.30455.B6.CrossRefPubMed
26.
go back to reference Mancia G, De Backer G, Dominiczak A, et al: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007, 25: 1751-62. 10.1097/HJH.0b013e3282f0580f.CrossRefPubMed Mancia G, De Backer G, Dominiczak A, et al: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007, 25: 1751-62. 10.1097/HJH.0b013e3282f0580f.CrossRefPubMed
27.
go back to reference Medeau V, Moreau F, Trinquart L, et al: Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Clin Endocrinol (Oxf). 2008, 69: 20-8. 10.1111/j.1365-2265.2008.03213.x.CrossRef Medeau V, Moreau F, Trinquart L, et al: Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Clin Endocrinol (Oxf). 2008, 69: 20-8. 10.1111/j.1365-2265.2008.03213.x.CrossRef
28.
go back to reference Mantero F, Terzolo M, Arnaldi G, et al: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000, 85: 637-44. 10.1210/jc.85.2.637.PubMed Mantero F, Terzolo M, Arnaldi G, et al: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000, 85: 637-44. 10.1210/jc.85.2.637.PubMed
29.
go back to reference Rossi GP, Seccia TM, Palumbo G, et al: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension. 2009, 55: 83-9. 10.1161/HYPERTENSIONAHA.109.139832.CrossRefPubMed Rossi GP, Seccia TM, Palumbo G, et al: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension. 2009, 55: 83-9. 10.1161/HYPERTENSIONAHA.109.139832.CrossRefPubMed
30.
go back to reference Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K: Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003, 88: 2489-94. 10.1210/jc.2002-021476.CrossRefPubMed Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K: Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003, 88: 2489-94. 10.1210/jc.2002-021476.CrossRefPubMed
31.
go back to reference Hiramatsu K, Yamada T, Yukimura Y, et al: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med. 1981, 141: 1589-93. 10.1001/archinte.141.12.1589.CrossRefPubMed Hiramatsu K, Yamada T, Yukimura Y, et al: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med. 1981, 141: 1589-93. 10.1001/archinte.141.12.1589.CrossRefPubMed
32.
go back to reference Campbell DJ, Nussberger J, Stowasser M, et al: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009, 55: 867-77. 10.1373/clinchem.2008.118000.CrossRefPubMed Campbell DJ, Nussberger J, Stowasser M, et al: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009, 55: 867-77. 10.1373/clinchem.2008.118000.CrossRefPubMed
33.
go back to reference Montori VM, Young WF: Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am. 2002, 31: 619-32. 10.1016/S0889-8529(02)00013-0. xi.CrossRefPubMed Montori VM, Young WF: Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am. 2002, 31: 619-32. 10.1016/S0889-8529(02)00013-0. xi.CrossRefPubMed
34.
go back to reference Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC: Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001, 37: 699-705. 10.1016/S0272-6386(01)80117-7.CrossRefPubMed Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC: Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001, 37: 699-705. 10.1016/S0272-6386(01)80117-7.CrossRefPubMed
35.
go back to reference Mulatero P, Rabbia F, Milan A, et al: Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002, 40: 897-902. 10.1161/01.HYP.0000038478.59760.41.CrossRefPubMed Mulatero P, Rabbia F, Milan A, et al: Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002, 40: 897-902. 10.1161/01.HYP.0000038478.59760.41.CrossRefPubMed
36.
go back to reference Willenberg HS, Schinner S, Ansurudeen I: New mechanisms to control aldosterone synthesis. Horm Metab Res. 2008, 40: 435-41. 10.1055/s-2008-1065336.CrossRefPubMed Willenberg HS, Schinner S, Ansurudeen I: New mechanisms to control aldosterone synthesis. Horm Metab Res. 2008, 40: 435-41. 10.1055/s-2008-1065336.CrossRefPubMed
37.
go back to reference Pizzolo F, Pavan C, Corrocher R, Olivieri O: Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. Am J Hypertens. 2007, 20: 1334-7. 10.1016/j.amjhyper.2007.08.009.CrossRefPubMed Pizzolo F, Pavan C, Corrocher R, Olivieri O: Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. Am J Hypertens. 2007, 20: 1334-7. 10.1016/j.amjhyper.2007.08.009.CrossRefPubMed
38.
go back to reference Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl. 1987, 5: S103-6.PubMed Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl. 1987, 5: S103-6.PubMed
39.
go back to reference Irony I, Kater CE, Biglieri EG, Shackleton CH: Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens. 1990, 3: 576-82.PubMed Irony I, Kater CE, Biglieri EG, Shackleton CH: Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens. 1990, 3: 576-82.PubMed
40.
go back to reference Rossi GP, Belfiore A, Bernini G, et al: Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens. 2007, 25: 1433-42. 10.1097/HJH.0b013e328126856e.CrossRefPubMed Rossi GP, Belfiore A, Bernini G, et al: Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens. 2007, 25: 1433-42. 10.1097/HJH.0b013e328126856e.CrossRefPubMed
41.
go back to reference Williams JS, Williams GH, Raji A, et al: Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006, 20: 129-36. 10.1038/sj.jhh.1001948.CrossRefPubMed Williams JS, Williams GH, Raji A, et al: Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006, 20: 129-36. 10.1038/sj.jhh.1001948.CrossRefPubMed
42.
go back to reference Young WF: Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007, 66: 607-18. 10.1111/j.1365-2265.2007.02775.x.CrossRef Young WF: Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007, 66: 607-18. 10.1111/j.1365-2265.2007.02775.x.CrossRef
43.
go back to reference Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K: Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab. 2001, 86: 4292-8. 10.1210/jc.86.9.4292.CrossRefPubMed Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K: Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab. 2001, 86: 4292-8. 10.1210/jc.86.9.4292.CrossRefPubMed
44.
go back to reference Stowasser M, Gordon RD: Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004, 217: 33-9. 10.1016/j.mce.2003.10.006.CrossRefPubMed Stowasser M, Gordon RD: Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004, 217: 33-9. 10.1016/j.mce.2003.10.006.CrossRefPubMed
45.
go back to reference Lumachi F, Marzola MC, Zucchetta P, et al: Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun. 2003, 24: 683-8. 10.1097/00006231-200306000-00011.CrossRefPubMed Lumachi F, Marzola MC, Zucchetta P, et al: Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun. 2003, 24: 683-8. 10.1097/00006231-200306000-00011.CrossRefPubMed
46.
go back to reference Vincent JM, Morrison ID, Armstrong P, Reznek RH: The size of normal adrenal glands on computed tomography. Clin Radiol. 1994, 49: 453-5. 10.1016/S0009-9260(05)81739-8.CrossRefPubMed Vincent JM, Morrison ID, Armstrong P, Reznek RH: The size of normal adrenal glands on computed tomography. Clin Radiol. 1994, 49: 453-5. 10.1016/S0009-9260(05)81739-8.CrossRefPubMed
47.
go back to reference White ML, Gauger PG, Doherty GM, et al: The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery. 2008, 144: 926-33. 10.1016/j.surg.2008.07.025. discussion 33.CrossRefPubMed White ML, Gauger PG, Doherty GM, et al: The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery. 2008, 144: 926-33. 10.1016/j.surg.2008.07.025. discussion 33.CrossRefPubMed
48.
go back to reference Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR: The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004, 25: 309-40. 10.1210/er.2002-0031.CrossRefPubMed Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR: The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004, 25: 309-40. 10.1210/er.2002-0031.CrossRefPubMed
49.
go back to reference Kempers MJ, Lenders JW, van Outheusden L, et al: Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009, 151: 329-37.CrossRefPubMed Kempers MJ, Lenders JW, van Outheusden L, et al: Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009, 151: 329-37.CrossRefPubMed
50.
go back to reference Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA: Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004, 136: 1227-35. 10.1016/j.surg.2004.06.051.CrossRefPubMed Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA: Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004, 136: 1227-35. 10.1016/j.surg.2004.06.051.CrossRefPubMed
51.
go back to reference Gicquel C, Bertagna X, Gaston V, et al: Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61: 6762-7.PubMed Gicquel C, Bertagna X, Gaston V, et al: Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61: 6762-7.PubMed
52.
go back to reference Rossi GP, Ganzaroli C, Miotto D, et al: Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens. 2006, 24: 371-9. 10.1097/01.hjh.0000202818.10459.96.CrossRefPubMed Rossi GP, Ganzaroli C, Miotto D, et al: Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens. 2006, 24: 371-9. 10.1097/01.hjh.0000202818.10459.96.CrossRefPubMed
53.
go back to reference Daunt N: Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005, 25 (Suppl 1): S143-58. 10.1148/rg.25si055514.CrossRefPubMed Daunt N: Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005, 25 (Suppl 1): S143-58. 10.1148/rg.25si055514.CrossRefPubMed
54.
go back to reference Magill SB, Raff H, Shaker JL, et al: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001, 86: 1066-71. 10.1210/jc.86.3.1066.PubMed Magill SB, Raff H, Shaker JL, et al: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001, 86: 1066-71. 10.1210/jc.86.3.1066.PubMed
55.
56.
go back to reference Young WF, Stanson AW: What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?. Clin Endocrinol (Oxf). 2009, 70: 14-7. 10.1111/j.1365-2265.2008.03450.x.CrossRef Young WF, Stanson AW: What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?. Clin Endocrinol (Oxf). 2009, 70: 14-7. 10.1111/j.1365-2265.2008.03450.x.CrossRef
57.
go back to reference Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T: Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism. 2002, 51: 350-5. 10.1053/meta.2002.30498.CrossRefPubMed Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T: Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism. 2002, 51: 350-5. 10.1053/meta.2002.30498.CrossRefPubMed
58.
go back to reference Stewart PM: Mineralocorticoid hypertension. Lancet. 1999, 353: 1341-7. 10.1016/S0140-6736(98)06102-9.CrossRefPubMed Stewart PM: Mineralocorticoid hypertension. Lancet. 1999, 353: 1341-7. 10.1016/S0140-6736(98)06102-9.CrossRefPubMed
59.
go back to reference Biller BM, Grossman AB, Stewart PM, et al: Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008, 93: 2454-62. 10.1210/jc.2007-2734.PubMedCentralCrossRefPubMed Biller BM, Grossman AB, Stewart PM, et al: Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008, 93: 2454-62. 10.1210/jc.2007-2734.PubMedCentralCrossRefPubMed
60.
go back to reference Vantyghem MC, Marcelli-Tourvieille S, Defrance F, Wemeau JL: [11beta-hydroxysteroide dehydrogenases. Recent advances]. Ann Endocrinol (Paris). 2007, 68: 349-56.CrossRef Vantyghem MC, Marcelli-Tourvieille S, Defrance F, Wemeau JL: [11beta-hydroxysteroide dehydrogenases. Recent advances]. Ann Endocrinol (Paris). 2007, 68: 349-56.CrossRef
61.
go back to reference Warnock DG: Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci. 2001, 322: 302-7. 10.1097/00000441-200112000-00002.CrossRefPubMed Warnock DG: Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci. 2001, 322: 302-7. 10.1097/00000441-200112000-00002.CrossRefPubMed
62.
go back to reference Pascoe L, Jeunemaitre X, Lebrethon MC, et al: Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 1995, 96: 2236-46. 10.1172/JCI118279.PubMedCentralCrossRefPubMed Pascoe L, Jeunemaitre X, Lebrethon MC, et al: Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 1995, 96: 2236-46. 10.1172/JCI118279.PubMedCentralCrossRefPubMed
63.
go back to reference Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005, 45: 1243-8. 10.1016/j.jacc.2005.01.015.CrossRefPubMed Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005, 45: 1243-8. 10.1016/j.jacc.2005.01.015.CrossRefPubMed
64.
go back to reference Sechi LA, Novello M, Lapenna R, et al: Long-term renal outcomes in patients with primary aldosteronism. Jama. 2006, 295: 2638-45. 10.1001/jama.295.22.2638.CrossRefPubMed Sechi LA, Novello M, Lapenna R, et al: Long-term renal outcomes in patients with primary aldosteronism. Jama. 2006, 295: 2638-45. 10.1001/jama.295.22.2638.CrossRefPubMed
65.
go back to reference Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E: A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008, 29: 133-54. 10.1210/er.2007-0030.CrossRefPubMed Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E: A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008, 29: 133-54. 10.1210/er.2007-0030.CrossRefPubMed
66.
go back to reference Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF: Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009, 53: 605-10. 10.1161/HYPERTENSIONAHA.108.122002.CrossRefPubMed Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF: Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009, 53: 605-10. 10.1161/HYPERTENSIONAHA.108.122002.CrossRefPubMed
67.
go back to reference Catena C, Colussi G, Nadalini E, et al: Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008, 168: 80-5. 10.1001/archinternmed.2007.33.CrossRefPubMed Catena C, Colussi G, Nadalini E, et al: Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008, 168: 80-5. 10.1001/archinternmed.2007.33.CrossRefPubMed
68.
go back to reference Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S, Heniford BT: Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery. 2005, 138: 1009-16. 10.1016/j.surg.2005.09.027.CrossRefPubMed Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S, Heniford BT: Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery. 2005, 138: 1009-16. 10.1016/j.surg.2005.09.027.CrossRefPubMed
69.
go back to reference Ishidoya S, Ito A, Sakai K, et al: Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2005, 174: 40-3. 10.1097/01.ju.0000162045.68387.c3.CrossRefPubMed Ishidoya S, Ito A, Sakai K, et al: Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2005, 174: 40-3. 10.1097/01.ju.0000162045.68387.c3.CrossRefPubMed
70.
72.
go back to reference Zarnegar R, Lee J, Brunaud L, et al: Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Surgery. 2007, 142: 921-9. 10.1016/j.surg.2007.09.001. discussion -9.CrossRefPubMed Zarnegar R, Lee J, Brunaud L, et al: Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Surgery. 2007, 142: 921-9. 10.1016/j.surg.2007.09.001. discussion -9.CrossRefPubMed
73.
go back to reference Shen WT, Lim RC, Siperstein AE, et al: Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg. 1999, 134: 628-31. 10.1001/archsurg.134.6.628.CrossRefPubMed Shen WT, Lim RC, Siperstein AE, et al: Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg. 1999, 134: 628-31. 10.1001/archsurg.134.6.628.CrossRefPubMed
74.
go back to reference Stowasser M, Klemm SA, Tunny TJ, Storie WJ, Rutherford JC, Gordon RD: Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol. 1994, 21: 319-22. 10.1111/j.1440-1681.1994.tb02520.x.CrossRefPubMed Stowasser M, Klemm SA, Tunny TJ, Storie WJ, Rutherford JC, Gordon RD: Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol. 1994, 21: 319-22. 10.1111/j.1440-1681.1994.tb02520.x.CrossRefPubMed
75.
go back to reference Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, Demura H: Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab. 1992, 75: 323-7. 10.1210/jc.75.1.323.PubMed Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, Demura H: Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab. 1992, 75: 323-7. 10.1210/jc.75.1.323.PubMed
76.
go back to reference Blumenfeld JD, Sealey JE, Schlussel Y, et al: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med. 1994, 121: 877-85.CrossRefPubMed Blumenfeld JD, Sealey JE, Schlussel Y, et al: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med. 1994, 121: 877-85.CrossRefPubMed
77.
go back to reference Ghose RP, Hall PM, Bravo EL: Medical management of aldosterone-producing adenomas. Ann Intern Med. 1999, 131: 105-8.CrossRefPubMed Ghose RP, Hall PM, Bravo EL: Medical management of aldosterone-producing adenomas. Ann Intern Med. 1999, 131: 105-8.CrossRefPubMed
78.
go back to reference Jeunemaitre X, Chatellier G, Kreft-Jais C, et al: Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol. 1987, 60: 820-5. 10.1016/0002-9149(87)91030-7.CrossRefPubMed Jeunemaitre X, Chatellier G, Kreft-Jais C, et al: Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol. 1987, 60: 820-5. 10.1016/0002-9149(87)91030-7.CrossRefPubMed
79.
go back to reference Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM: Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol. 2003, 169: 32-5. 10.1016/S0022-5347(05)64028-1.CrossRefPubMed Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM: Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol. 2003, 169: 32-5. 10.1016/S0022-5347(05)64028-1.CrossRefPubMed
80.
go back to reference Mulatero P, Bertello C, Rossato D, et al: Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008, 93: 1366-71. 10.1210/jc.2007-2055.CrossRefPubMed Mulatero P, Bertello C, Rossato D, et al: Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008, 93: 1366-71. 10.1210/jc.2007-2055.CrossRefPubMed
81.
go back to reference Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ: Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003, 88: 3637-44. 10.1210/jc.2002-022051.CrossRefPubMed Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ: Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003, 88: 3637-44. 10.1210/jc.2002-022051.CrossRefPubMed
82.
go back to reference Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL: Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism. J Hum Hypertens. 2009, 23: 292-4. 10.1038/jhh.2008.108.CrossRefPubMed Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL: Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism. J Hum Hypertens. 2009, 23: 292-4. 10.1038/jhh.2008.108.CrossRefPubMed
83.
go back to reference Auchus RJ, Michaelis C, Wians FH, et al: Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009, 249: 318-21. 10.1097/SLA.0b013e3181961d77.CrossRefPubMed Auchus RJ, Michaelis C, Wians FH, et al: Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009, 249: 318-21. 10.1097/SLA.0b013e3181961d77.CrossRefPubMed
Metadata
Title
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism
Authors
Laurence Amar
Pierre-François Plouin
Olivier Steichen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2010
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-5-9

Other articles of this Issue 1/2010

Orphanet Journal of Rare Diseases 1/2010 Go to the issue